Pseudoporphyria: A Case Report.

Indian J Dermatol

Published: June 2015

Download full-text PDF	Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4458981	PMC
http://dx.doi.org/10.4103/0019-5154.156480	DOI Listing

Publication Analysis

pseudoporphyria case

case report

pseudoporphyria

report

Adv Skin Wound Care

August 2024

- The goal of the educational activity is to enhance understanding of how pseudoporphyria manifests in patients.
- It's aimed at healthcare professionals like doctors and nurses who focus on skin and wound care.
- Participants will learn to recognize pseudoporphyria's symptoms, differentiate it from other conditions that cause blistering, and understand treatment options.

Dermatol Online J

April 2024

Complete Dermatology, Conroe, Texas, USA.

Drug-induced pseudoporphyria is often caused by NSAIDs like naproxen and ibuprofen, but this case highlights meloxicam as a potential cause.
A 55-year-old woman with multiple health issues developed skin blisters on her feet, later diagnosed as pseudoporphyria linked to her meloxicam use.
The patient's symptoms improved after stopping meloxicam, suggesting that awareness of this medication's risk can aid dermatologists in diagnosis and treatment.

Cureus

April 2024

Dermatology, Jawaharlal Nehru Medical College, Datta Meghe Institute of Higher Education and Research, Wardha, IND.

- Pseudoporphyria is a rare skin condition that resembles porphyria cutanea tarda (PCT), and distinguishing between the two is crucial for accurate diagnosis.
- It’s linked to chronic kidney failure, certain medications, and tanning bed use, and can cause skin issues like fragility, blisters, and scarring, especially in sun-exposed areas.
- A case report highlights a 20-year-old male diagnosed with pseudoporphyria after ruling out true porphyria, who was treated with hydroxychloroquine sulfate and advised to take strict sun protection measures.